Piramal Pharma Limited has announced its financial results for the third quarter and nine months of the fiscal year, highlighting significant revenue growth and operational achievements. The company reported a notable increase in revenue driven by its Contract Development and Manufacturing Organization and Complex Hospital Generics segments. Additionally, Piramal Pharma has made strides in sustainability by converting a coal-fired steam boiler to a biomass briquette system, significantly reducing greenhouse gas emissions. The results reflect a strong performance across various business segments, with a focus on innovation and market expansion.
Piramal Pharma Limited has informed the Exchange regarding a press release dated January 28, 2025, titled "Press Release Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December, 2024".